Current Neuro-Oncology
Volume
24 Number 5
15 March 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 5, 15 March
Ma
C, Nguyen HPT, Jones JJ, Stylli SS, Whitehead CA, Paradiso L,
Luwor RB, Areeb Z, Hanssen E, Cho E, Putz U, Kaye AH, Morokoff
AP.
Extracellular
Vesicles
Secreted
by Glioma Stem Cells Are Involved in Radiation Resistance and
Glioma
Progression.
Int
J Mol Sci. 2022 Mar 2;23(5):2770∟.
doi: 10.3390/ijms23052770∟.
PMID: 35269915∟.
Laboratory investigation. ˍ
de
Marcellus C, Tauziède-Espariat A, Cuinet A, Pasqualini C,
Robert MP, Beccaria K, Puget S, Boddaert N, Figarella-Branger D,
De Carli E, Bourdeaut F, Leblond P, Fouyssac F, Andre N, Bertozzi
AI, Butel T, Dufour C, Valteau-Couanet D, Varlet P, Grill J.
The
role of irinotecan-bevacizumab as rescue regimen in
children
with low-grade gliomas: a retrospective nationwide study in 72
patients.
J
Neurooncol. 2022 Mar 3∟.
doi: 10.1007/s11060-022-03970-ˍ.
PMID: 35239111∟.
Observational study˰ ˍ
Kozlikina
EI, Trifonov IS, Sinkin MV, Krylov VV, Loschenov VB.
The
Combined Use
of 5-ALA and Chlorin e6 Photosensitizers for Fluorescence-Guided
Resection and
Photodynamic Therapy under Neurophysiological Control for
Recurrent
Glioblastoma
in the Functional Motor Area after Ineffective Use of 5-ALA:
Preliminary
Results.
Bioengineering
(Basel). 2022 Mar 3;9(3):10∟.
doi: 10.3390/bioengineering9030104∟.
PMID: 35324793∟.
Case report. ˍ
Xu
K, Ramesh K, Huang V, Gurbani SS, Cordova JS, Schreibmann E,
Weinberg BD, Sengupta S, Voloschin AD, Holdhoff M, Barker PB,
Kleinberg LR, Olson JJ, Shu HG, Shim H.
Final
Report on Clinical Outcomes and Tumor Recurrence Patterns of a
Pilot
Study Assessing Efficacy of Belinostat (PXD-101) with
Chemoradiation for
Newly
Diagnosed Glioblastoma.
Tomography.
2022 Mar 3;8(2):688-700∟.
doi: 10.3390/tomography8020057∟.
PMID: 35314634∟.
Interventional study. ˍ
Blonski
M, Obara T, Brzenczek C, Pouget C, Dillier C, Meyer M, Lavigne L,
Forthoffer N, Broussois A, Gauchotte G, Baron MH, Rech F, Mézières
S, Gaudeau Y, Verger A, Vogin G, Anxionnat R, Moureaux JM,
Taillandier L.
Initial
PCV Chemotherapy
Followed by Radiotherapy Is Associated With a Prolonged Response
But
Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients.
Front
Oncol. 2022 Mar 4;12:827897∟.
doi: 10.3389/fonc.2022.827897∟.
PMID: 35311144∟.
Observational study.
ˍ
Jakola
AS, Pedersen LK, Skjulsvik AJ, Myrmel K, Sjåvik K, Solheim
O.
The
impact
of resection in IDH-mutant WHO grade 2 gliomas: a retrospective
population-based
parallel cohort study.
J
Neurosurg. 2022 Mar 4, 2022:1-8∟.
doi: 10.3171/2022.1.JNS212514∟.
PMID: 35245899∟.
Observational study˰ ˍ
Kim
HJ, Lee JH, Kim Y, Lim DH, Park SH, Ahn SD, Kim IA, Im JH, Chung
JW, Kim JY, Kim IH, Yoon HI, Suh CO.
Suggestions
for Escaping the Dark Ages for
Pediatric
Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy:
Analysis of
Prognostic Factors from the National Multicenter Study.
Cancer
Res Treat. 2022 Mar 4∟.
doi: 10.4143/crt.2021.1514∟.
PMID: 35255651∟.
Observational study. ˍ
Picariello
S, Spennato P, Roth J, Shimony N, Marini A, De Martino L, Nicosia
G, Mirone G, De Santi MS, Savoia F, Errico ME, Quaglietta L,
Costantini S, Cinalli G.
Posterior
Fossa Tumours in the First Year of Life: A Two-Centre
Retrospective
Study.
Diagnostics
(Basel). 2022 Mar 4;12(3):635∟.
doi: 10.3390/diagnostics12030635∟.
PMID: 35328188∟.
Observational study. ˍ
Metts
J, Harrington B, Salman E, Bradfield SM, Flanary J, Mosha M,
Amankwah E, Stapleton S.
A
phase I study of irinotecan and temozolomide with bevacizumab
in
children with recurrent/refractory central nervous system
tumors.
Childs
Nerv Syst. 2022 Mar 8∟.
doi: 10.1007/s00381-022-05479-7∟.
PMID: 35260913∟.
Interventional study˰ ˍ
Shin
M, Kim OJ, Yang S, Choe SA, Kim SY.
Different
Mortality Risks of Long-Term Exposure to Particulate Matter across
Different Cancer Sites.
Int
J Environ Res Public Health. 2022 Mar 8;19(6):3180∟.
doi: 10.3390/ijerph19063180∟.
PMID: 35328866∟.
Observational study. ˍ
Loeb
DM, Lee JW, Morgenstern DA, Samson Y, Uyttebroeck A, Lyu CJ, Van
Damme A, Nysom K, Macy ME, Zorzi AP, Xiong J, Pollert P, Joerg I,
Vugmeyster Y, Ruisi M, Kang HJ.
Avelumab
in paediatric patients with refractory or relapsed solid
tumours:
dose-escalation results from an open-label, single-arm, phase 1/2
trial.
Cancer
Immunol Immunother. 2022 Mar 9∟.
doi: 10.1007/s00262-022-03159-8∟.
PMID: 35262780∟.
Interventional study. ˍ
*
Barragán-Pérez
EJ, Alvarez-Amado DE, Dies-Suarez P, Tobón SH,
García-Beristain JC, Peñaloza-González
JG.
Compassionate
use of Quantum Magnetic
Resonance
Therapy for treatment of children with Diffuse Brainstem Glioma in
Mexico
City: a single institutional experience.
J
Neurooncol. 2022 Mar 10∟.
doi: 10.1007/s11060-022-03972-2∟.
PMID: 35266065∟.
Observational study˰ ˍ
Guarnaccia
L, Navone SE, Masseroli MM, Balsamo M, Caroli M, Valtorta S,
Moresco RM, Campanella R, Schisano L, Fiore G, Galiano V, Garzia
E, Appiani GC, Locatelli M, Riboni L, Marfia G.
Effects
of Metformin as Add-On Therapy against
Glioblastoma:
An Old Medicine for Novel Oncology Therapeutics.
Cancers
(Basel). 2022 Mar 10;14(6):1412∟.
doi: 10.3390/cancers14061412∟.
PMID: 35326565∟.
Laboratory investigation. ˍ
Lin
GS, Wang WW, Lin H, Lin RS.
Bevacizumab
Combined with Intensity-Modulated
Radiation
Therapy on Cognitive and Coagulation Function in Postoperative
Glioma
Patients.
J
Healthc Eng. 2022 Mar 12;2022:9367919∟.
doi: 10.1155/2022/9367919∟.
PMID: 35313514∟.
Observational study. ˍ
Caramanna
I, de Kort JM, Brandes AA, Taal W, Platten M, Idbaih A, Frenel JS,
Wick W, Preetha CJ, Bendszus M, Vollmuth P, Reijneveld JC, Klein
M.
Corticosteroids
use and neurocognitive functioning in patients with recurrent
glioblastoma: Evidence from European Organization for Research and
Treatment of Cancer (EORTC) trial 26101.
Neurooncol
Pract. 2022 Mar 13;9(4):310-316∟.
doi: 10.1093/nop/npac022∟.
PMID: 35855458∟.
Observational
study.
ˍ
Gupta
T, Kalra B, Goswami S, Deodhar J, Rane P, Epari S, Moiyadi A,
Dasgupta A, Chatterjee A, Chinnaswamy G.
Neurocognitive
function and survival in children with average-risk
medulloblastoma treated with hyperfractionated radiation therapy
alone: Long-term mature outcomes of a prospective
study.
Neurooncol
Pract. 2022 Mar 13;9(3):236-245∟.
doi: 10.1093/nop/npac020∟.
PMID: 35601967∟.
Observational study˰ ˍ
Jiang
H, Zeng W, Zhang X, Pei Y, Zhang H, Li Y.
The
role of gut microbiota in
patients
with benign and malignant brain tumors: a pilot
study.
Bioengineered.
2022 Mar 15;13(3):7847-7859∟.
doi: 10.1080/21655979.2022.2049959∟.
PMID: 35291914∟.
Interventional study. ˍ
Jajodia
A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola
M.
Combined
Diagnostic Accuracy of Diffusion and Perfusion MR Imaging to
Differentiate
Radiation-Induced Necrosis from Recurrence in
Glioblastoma.
Diagnostics
(Basel). 2022 Mar 15;12(3):718∟.
doi: 10.3390/diagnostics12030718∟.
PMID: 35328270∟.
Observational study. ˍ
Mishra
H, Pahwa B, Agrawal D, M Ch MS, M Ch SSK.
Gamma
knife radiosurgery as
an
efficacious treatment for paediatric central nervous system
tumours: a
retrospective
study of 61 neoplasms.
Childs
Nerv Syst. 2022 Mar 15∟.
doi: 10.1007/s00381-022-05463-1∟.
PMID: 35290486∟.
Observational study˰ ˍ
Pareira
ES, Shibuya M, Ohara K, Nakagawa Y, Kanazawa T, Kamamoto D, Kato
Y, Arai E, Aimono E, Yoshida K, Nishihara H, Kanai Y, Sasaki
H.
The
oligodendroglial
histological features are not independently predictive of
patient
prognosis in lower-grade gliomas.
Brain
Tumor Pathol. 2022 Mar 15∟.
doi: 10.1007/s10014-022-00426-5∟.
PMID: 35292862∟.
Observational study˰ ˍ
Parenrengi
MA, Prastikarunia R, Suryaningtyas W.
Leptomeningeal
and subependymal
seeding of diffuse intrinsic pontine glioma: a case report.
Childs
Nerv Syst. 2022 Mar 15∟.
doi: 10.1007/s00381-022-05482-y∟.
PMID: 35290487∟.
Case report˰ ˍ